Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Dec 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- S&P 500, Nasdaq fall as investors juggle earnings, Mideast risks and tariffs
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil retreats from above $100, still set for weekly rise on Middle East escalation
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- Meta’s new seller app hits eBay where it hurts most
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
LIXT exchanges preferred stock for common shares with Orbit Capital
December 31, 2025 4:03 PM ESTLixte Biotechnology Holdings Inc. (NASDAQ: LIXT) completed a share exchange with Orbit Capital Inc. on December 30, 2025, according to a company statement.
Under the agreement, Orbit Capital exchanged 2,700 shares of Lixte's Series C Preferred Stock for 700,000 shares of common stock and 200 ordinary shares of Liora... More
